,Group,Gilenya_pat,Gilenya_relapse,Gilenya_relapse_rate,Tecfidera_pat,Tecfidera_relapse,Tecfidera_relapse_rate,actual_treatment,expect_Gilenya_relapse_rate,expect_Tecfidera_relapse_rate,expect_treatment
training,lowest 35%,605,68,0.112396694214876,324,80,0.246913580246914,-0.134516886032038,0.11582594431924,0.246568493626226,-0.130742549306985
training,middle 30%,507,34,0.0670611439842209,290,14,0.0482758620689655,0.0187852819152554,0.0602676979123612,0.0737824140093397,-0.0135147160969785
training,highest 35%,617,101,0.163695299837925,312,32,0.102564102564103,0.0611311972738229,0.163917067456435,0.0956569850772994,0.0682600823791358
test,lowest 50%,215,28,0.130232558139535,117,16,0.136752136752137,-0.00651957861260188,0.1120638543479,0.210951470958192,-0.0988876166102919
test,highest 50%,205,24,0.117073170731707,126,14,0.111111111111111,0.00596205962059622,0.13816695801639,0.0864841866926496,0.0516827713237402
